| Date | Time | Source | Headline | Symbol | Company |
| 08/04/2011 | 05:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 08/04/2011 | 04:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 08/04/2011 | 04:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 08/04/2011 | 04:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 08/04/2011 | 02:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 08/04/2011 | 02:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 06:53 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 06:52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 06:39 | Business Wire | CPEX Completes Sale to FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 05:59 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 05:56 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 04:46 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 04:42 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 06/04/2011 | 03:53 | PR Newswire (US) | Footstar Completes Acquisition of CPEX Pharmaceuticals, Inc. | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 01/04/2011 | 01:54 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 31/03/2011 | 01:11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 25/03/2011 | 00:21 | Business Wire | CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 24/03/2011 | 06:00 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 23/03/2011 | 22:00 | Business Wire | CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 23/03/2011 | 21:02 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 22/03/2011 | 23:30 | PR Newswire (US) | Mangrove Partners Notes CPEX Stock Trading Above Offer Price | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 22/03/2011 | 07:31 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 22/03/2011 | 02:56 | Business Wire | CPEX Advises Stockholders to Vote Today for the All-Cash, Premium FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 21/03/2011 | 23:30 | PR Newswire (US) | Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals, Inc. and Reaffirms Proposed Recapitalization and In | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 19/03/2011 | 07:27 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 19/03/2011 | 07:21 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 19/03/2011 | 00:36 | Business Wire | CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 18/03/2011 | 08:13 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 18/03/2011 | 08:09 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 18/03/2011 | 00:34 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |